18 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Intra.Ox 2.0 Handheld Tissue Oximeter

FDA 510(k)
FDA Class 2 ·Cardiovascular

CLEARARCH

FDA 510(k)
FDA Class 2 ·Dental

MC-245, MC-246, MC-247, MC-341, MC-343, MC-344

FDA 510(k)
FDA Class 2 ·General Hospital

KRD DEVICE, EMBOLIZATION, VASCULAR

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·September 19, 2019

PORTABLE OXYGEN GENERATOR (CONCENTRATOR, HOMEFILL)

FDA Adverse Event
Malfunction ·INVACARE FLORIDA OPERATIONS·Product code CAW·October 22, 2014

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·August 4, 2011

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code IOR·June 26, 2013

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Injury ·COOK INC·Product code KRD·June 20, 2019

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·September 17, 2018

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·September 17, 2018

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·January 2, 2020

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·January 2, 2020

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·March 11, 2020

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·July 31, 2019

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Injury ·COOK INC·Product code KRD·February 25, 2019

RETRACTA DETACHABLE EMBOLIZATION COIL

FDA Adverse Event
Malfunction ·COOK INC·Product code KRD·February 3, 2020

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018

TrueBeam Radiotherapy Delivery System version 2.0 and 2.5 EDGE Radiotherapy Delivery System version 2.0 and 2.5 Product Usage: The TrueBeam delivery systems are intended to provide radiotherapy and stereotactic radiosurgery for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems·October 10, 2018